Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your Welcome ny.girl. Sometimes the truth hurts if you find out about it. You sure won't watching Fake News Broadcasts. The other thing good is to not be led around by a ring in one's nose.
I feel the same rs138. I have been here with another stock before. Hopefully this outcome will be different.
So, let me ask the board. Say an 8K comes out and a company joins with VGTL. Won't VGTL have to be current on August 13th to be able to trade on the exchanges? And won't they have to be current by the middle of September to be able to be listed any longer?
What is holding this company stock back? It seems to be hitting on all 12 cylinders.
A lot of posts saying you can short a penny stock and a lot saying you cannot. All I know is that if you cannot short a penny stock, it does not keep entities from doing all they can to drive the price down so they can buy low and sell high multiple times during the life of the company. This is an obvious observation.
CDC has just announced they will revoke the emergency use authorization of the RT-PCR tests first introduced in 2/20. “CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS CoV-2 and influenza viruses.”
To be clear, this is not a new development. These assays have been known for years to be unable to distinguish between the different types of coronaviruses, but they ran with it anyway. According to the CDC website [emphasis added]:
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
…
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
Why the sudden change?
According to J.D. Rucker at The Liberty Daily:
The RT-PCR assays could detect the presence of a coronavirus from a swab in real-time, making it a good indicator of the potential for Covid-19 infection. In a sane world that wasn’t driven by a nefarious agenda, positive results on the RT-PCR tests would have been treated as indicators that someone needed to get a real test, like an antigen test, to determine if they were infected. But this isn’t a sane world and the powers-that-be saw an opportunity to bump up numbers to drive panic. They ran with it, and revoking the EUA means they’re done with that particular type of fearmongering. The RT-PCR assays served their purpose.
The other reason for this move is very concerning. This shift and its timing both indicate the powers-that-be are anticipating a need to differentiate between the various coronaviruses. If it really is the need to differentiate Covid-19 and influenza as they’re claiming, then that jibes with the sudden push to maximize or even mandate flu vaccines within months. If that’s the scenario they have planned, expect a sudden surge in flu cases after a year where they “miraculously” disappeared thanks to RT-PCR tests claiming everything was Covid-19.
So we have to ask why is it that it’s important to separate them NOW? What fresh variant is headed our way? What infringements on our liberty do they have in mind? How are they going to gin up fear for a disease that only affects co-morbidities, and even then has an almost 100% recovery rate?
First, stop listening to the bots on social media. Second, follow us for more updates.
Me too. I did OK, but not the giant cigar I was hoping for.
Absolutely did. 9 million shares. So people can cheer and jeer at my decision. I decided that I do not trust the SEC nor the so called management of this company.
I sold all of mine. Bye Bye Good luck if not out yet.
What do you mean by do not believe the reports?
So, this means more GTXO mask sales, maybe?
What good is an 8K if all the quarterly and yearly reports are not current?
Sad situation. Sorry
If all human beings used a GTXO tracker it would work great for the globalist.
Great Point Samsleiman.
Too much spike protein in their systems from the jab and then more from Covid. Face it America, this is one big pharma trial on a large portion of the population with coverup of what the real effects are on human being guinea pigs. Of course the government gets control of the population and makes them more dependent. That is the Globalist goal. But don't forget big pharma makes a killing with help from our tax dollars through the CDC. More to the story than meets the eye.
What is going to propel people to bring a ton of money here nest month?
Funny, Before I read your post about closing out the trash, I just finished doing the same thing. No more prayers for them.
carolinatiger, Who was Hired today?
Tell me I-Glow, How does one short NPHC? So, help me out please. I think it must be able to happen, even though it is said it can't be done. There usually is a way around most rules.
At least the company is current and will not be delisted as so many others are. GTXO seems to be on track to start bringing in some revenue.
Good to know that ALKM is current! So many others are about to be delisted due to failure of their company management to take care of business. I feel a lot better or staying pat here with all my shares I have accumulated over the years. Holding strong due to path shown the company has taken.
Well, The problem is going to be solved. The question is when. I will not be able to trade NPHC after August 13th. I just hope that the company gets current before delisting date in September. I have been here will all the shares I have accumulated over the years and never sold any. I have faith that my bet will payoff. Company playing with fire IMO. I had another stock that I purchased and held a long time that got delisted before the were current, even though they had been working fast and furious to get caught up on several years of delinquency. That company got delisted and I learned at that time once a company gets delisted the vast majority never get relisted. Total loss for me even though I now still have shares in a private company. I hope like heck that is not the result here. I wish the SEC would get out of the way soon. I am one to believe the SEC is not to be trusted and are more detrimental to investors in a lot of cases that protective. I am all or nothing on this stock and putting my faith into the Company to perform for their shareholders.
Nutra Pharma Engages Government Affairs Consulting Firm
Nutra Pharma is working with Washington DC-based government affairs consultants and lobbyists to support their Nyloxin® line of pain relief products as well as act as liaisons to governmental agencies.
July 15, 2021 -- Plantation, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™ and Equine Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that they had engaged the Washington DC-based government affairs consulting firm, Vitello Consulting. The firm will work with elected officials as well as governmental agencies to increase the awareness of Nutra Pharma’s products and technologies with the goal of improving sales, garnering grants and potentially speeding drug applications.
“We are excited to work with Vitello Consulting as our liaisons with governmental agencies and elected officials,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “We have high hopes that this relationship will allow us to get our products into the hands of the people that need them most. This includes our Veterans in chronic pain,” he continued. “One of the first projects for this new relationship will be working with the Veterans Administration to pave the way into VA hospitals and clinics. They will also help us navigate government bureaucracies that include the FDA, the SEC and buyers on the Federal Supply Schedule,” he concluded.
Nutra Pharma has several projects in front of governmental agencies at this time. The Company has previously announced their work with the Defense Threat Reduction Agency (DTRA) on their potential nerve agent counter-measures. Nutra Pharma had also been granted Orphan Designation by the FDA for their Multiple Sclerosis drug, RPI-78M and has stated plans to move the drug into clinical trials.
“We’re thrilled to be working with Nutra Pharma”, commented Frank Vitello, president of Vitello Consulting. “The pipeline Rik and his team have developed has them positioned for immediate success and I’m confident that together we’ll cross the goal line on a number of these projects in the coming months,” he concluded.
Nyloxin® is a safe, non-narcotic, and non-addictive Homeopathic pain reliever for the relief of pain without impairing cognitive function. Nyloxin® offers several benefits as pain relievers and anti-inflammatory agents. Nyloxin® has a well-defined safety profile. Since the early 1930s, the active pharmaceutical ingredient (API), Asian cobra venom, has been studied in more than 46 human clinical studies.
RPI-78M was originally derived from an extract of cobra venom and is an antagonist of the nicotinic acetylcholine receptor. The drug has a remarkably low toxicity with a very large therapeutic window. Scientific publications have demonstrated that native and modified neurotoxins can protect nerve cells from early cell death. Furthermore, it is expected that RPI-78M may be beneficial in neuromuscular disorders where the activity of nicotinic acetylcholine receptor has been compromised. The proprietary technology is covered by patents describing the application and use of RPI-78M in the treatment of autoimmune diseases, including Multiple Sclerosis (MS).
About Vitello Consulting
Vitello Consulting is a full-service government affairs consulting firm assisting clients whose concerns and interests intersect with the United States Congress, federal agencies, foreign governments, and international regulatory organizations. We have successfully led legislative and policy efforts at the federal and state level, managed issue campaigns nationally and locally, aided clients with new ventures and acquisitions, market penetration, and in developing branding and partnering opportunities.
For additional information about Vitello Consulting, visit:
https://www.vitelloconsulting.com
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin® and Pet Pain-Away™. For additional information about Nutra Pharma, visit:
http://www.NutraPharma.com or
http://www.nyloxin.com
http://www.petpainaway.com
SEC Disclaimer
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The engagement of Vitello Consulting should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
# # #
Press Release
Post not marked as liked
Is ALKM current?
August 13th you will only be able to sell the security on TD Ameritrade. No more market for stock if company is not current by then. That is the notice I received.
Dear XXXXXXXX,
On September 28, 2021, new amendments adopted by the U.S. Securities Exchange Commission (SEC) go into effect to enhance investor protection and improve issuer transparency. These amendments restrict the ability of market makers to publish quotations for those companies that have not made required current financial and company information available to regulators and investors.
Ahead of the regulatory enforcement date, we will only accept orders to liquidate positions (i.e. no new buy orders) starting August 13, 2021. After the amendment officially goes into effect on September 28, 2021, it may be more difficult to liquidate these securities. Quoting and market liquidity may also be very limited.
What this means for your account(s).
You are receiving this notification because you currently hold one or more of the impacted securities in your account. We're including the list below but be aware that it may not include all of your impacted securities. There is also a chance that the impacted companies could come into compliance with the regulatory requirements ahead of this date and be removed from the list. For a current list of all securities (which is subject to change), please visit www.tdameritrade.com/retail-en_us/resources/pdf/TDA101550.pdf.
If NPHC continues at the same rate of speed it has so far in getting current, it would happen some time next year. Unfortunately.
Rick did not manipulate the price that was a false accusation.
Anybody know when this stock will take off?
Why is it Pennies soon?
Yes, I am ready for the verdict and move on to bigger and better things.
You said companies. What companies?
If you think about it, some entity or individual brought forth the charges that the SEC is trying to prosecute NPHC on. That would mean they felt done wrong by NPHC or they are working for another company trying to sabotage NPHC. It is Obvious to me.
It seems like that merger must not of happened or if it did it was done in stealth mode and now the new player takes over. This is what sucks about non reporting pink stocks. No one knows what is going on.
I sure am glad to be loaded with ALKM Shares. Feels real good!!
I don't know which BS merger. I don't have a case.
I missed that part. Makes sense now.
Obviously I saw that, but do not understand why it would have a current date on top. Let us think positively that the publisher forgot to insert the most recent merger. The one we are expecting.
The article was as you see below, recent on the web. That is what was confusing.
MICROCAP DAILY
Monday, June 28, 2021
MICRO CAP INSIDERMEDIA & TECHNOLOGYEMERGING MARKETSSTREET WATCHSMALL CAPSABOUT MCD
MICRO CAP INSIDERSMALL CAPS
The Real Story on VGTel Inc (OTCMKTS:VGTL)
The story I posted below does not make any sense to me. Anybody Else?